Hong Kong · SFC › People
Cao, Yanling
曹彥凌
Formerly licensedCE AOC722SFC register ↗
Age about 43 (estimated) · Licensed about 1 year at 1 identified firm
SFC licence history
Back to top ↑| Firm | Role | Regulated activities | From | To |
|---|---|---|---|---|
| GOLDMAN SACHS (ASIA) L.L.C.高盛(亞洲)有限責任公司 | Licensed representative | Type 1, Type 6 | 1 Nov 2006 | 17 Nov 2007 |
Directorships of Hong Kong listed companies
Back to top ↑| Company | Position | From | To |
|---|---|---|---|
| Ocumension Therapeutics歐康維視生物1477 | Non-Executive Director | 18 Jun 2019 | present (as of 24 Dec 2025) |
| WuXi Biologics (Cayman) Inc.2269 | Non-Executive Director | 11 May 2016 | present (as of 24 Dec 2025) |
| CStone Pharmaceuticals基石藥業2616 | Non-Executive Director | 15 May 2019 | 18 Jan 2023 |
| Antengene Corporation Limited德琪醫藥有限公司6996 | Non-Executive Director | 4 Feb 2019 | 16 Dec 2021 |
| JW (Cayman) Therapeutics Co. Ltd2126 | Independent Non-Executive Director | 22 May 2020 | 3 Dec 2021 |
| Hygeia Healthcare Holdings Co., Limited海吉亞醫療控股有限公司6078 | Non-Executive Director | 3 Jun 2019 | 30 Mar 2021 |
Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.